Olema Pharmaceuticals, Inc. Common Stock

OLMANASDAQUSD
13.59 USD
0.00 (0.00%)AT CLOSE (11:59 AM EDT)
13.61
0.02 (0.15%)
POST MARKET (AS OF 07:43 PM EDT)
Post Market
AS OF 07:43 PM EDT
13.61
0.02 (0.15%)
🔴Market: CLOSED
Open?$13.53
High?$13.71
Low?$13.05
Prev. Close?$13.59
Volume?1.2M
Avg. Volume?943.8K
VWAP?$13.31
Rel. Volume?1.30x
Bid / Ask
Bid?$11.67 × 100
Ask?$15.59 × 100
Spread?$3.92
Midpoint?$13.63
Valuation & Ratios
Market Cap?1.2B
Shares Out?87.3M
Float?63.4M
Float %?80.7%
P/E Ratio?N/A
P/B Ratio?2.47
EPS?-$2.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Employees
137
Market Cap
1.2B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-11-19
Address
780 BRANNAN STREET
SAN FRANCISCO, CA 94103
Phone: (415) 651-3316
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?10.88Strong
Quick Ratio?10.88Strong
Cash Ratio?1.11Strong
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
2.47CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-5.7CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-38.5%WEAK
ROA?
-34.9%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$1.1B
Fundamentals ratios updated end of day